Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Virtual Event – Pathophysiology Of Agitation Associated With Alzheimer’s Dementia (AD) – The Potential Role Of The Norepinephrine, Serotonin & Dopamine (NSD) Neurotransmitter Systems

In this presentation, topics of discussion are:

  • Loss of behavior regulation in agitation associated with AD
  • Monoamine systems in agitation associated with AD pathophysiology
    • Norepinephrine
    • Serotonin
    • Dopamine

Featuring

Becky-Wong

Becky Wong, PharmD, MBA

Medical Science Director

E. Jeffrey-Greenberg

E. Jeffrey Greenberg, MD

Neurologist at Princeton & Rutgers Neurology, P.A., Co-Founder of Advanced Clinical Institute

More
Dr. Jeffrey Greenberg, a native of Philadelphia, joined Princeton & Rutgers Neurology in 2003. He received his Bachelor’s degree in English from Cornell University and his medical degree from Drexel University, College of Medicine. He completed his Neurology residency at the Albert Einstein College of Medicine in New York, serving as Chief Resident in his final year. He subsequently completed an EMG/Neuromuscular fellowship at Albert Einstein. He is Board Certified in Neurology by the American Board of Psychiatry and Neurology and also Board Certified by the American Associate of Neuromuscular and Electrodiagnostic Medicine. Dr. Greenberg now focuses his practice on Parkinson’s Disease, Dementia, Multiple Sclerosis, and Neuromuscular Disease. Additionally, he has experience as a Principle Investigator for Alzheimer’s disease clinical trials and remains involved in the field.

Becky Wong, PharmD, MBA is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) E. Jeffrey Greenberg, MD is a paid speaker on behalf of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources